ChemBriefCSL Stock Plunges to 2017 Low Following U.S. Military Flu Vaccine Mandate Reversal
Australian biotech CSL shares hit 2017 lows after the U.S. military scrapped its flu vaccine mandate, threatening revenue from its key Seqirus division amidst ongoing earnings struggles.
reuters · 2026-04-22 17:47 UTC